☆ 4.4 Letter

Medications for Opioid Use Disorder During the Prenatal Period and Infant Outcomes

JAMA PEDIATRICS (2023)

Related references

Note: Only part of the references are listed.

Article Substance Abuse

Maternal opioid exposure, neonatal abstinence syndrome, and infant healthcare utilization: A retrospective cohort analysis

Jean Y. Ko et al.

Summary: This longitudinal cohort study found that infants with maternal opioid exposure and/or NAS had higher healthcare utilization in the first year after birth, including increased rates of hospitalization and emergency department visits compared to infants without opioid exposure or NAS.

DRUG AND ALCOHOL DEPENDENCE (2021)

Add to Collection

Article Health Care Sciences & Services

Five-Year Outcomes Among Medicaid-Enrolled Children With In Utero Opioid Exposure

Marian P. Jarlenski et al.

HEALTH AFFAIRS (2020)

Add to Collection

Article Substance Abuse

Pregnant women with opioid use disorder and their infants in three state Medicaid programs in 2013-2016

Lisa Clemans-Cope et al.

DRUG AND ALCOHOL DEPENDENCE (2019)

Add to Collection

Article Medicine, General & Internal

Prenatal Risk Factors and Perinatal and Postnatal Outcomes Associated With Maternal Opioid Exposure in an Urban, Low-Income, Multiethnic US Population

Romuladus E. Azuine et al.

JAMA NETWORK OPEN (2019)

Add to Collection

Medications for Opioid Use Disorder During the Prenatal Period and Infant Outcomes

Related references

Maternal opioid exposure, neonatal abstinence syndrome, and infant healthcare utilization: A retrospective cohort analysis

Five-Year Outcomes Among Medicaid-Enrolled Children With In Utero Opioid Exposure

Pregnant women with opioid use disorder and their infants in three state Medicaid programs in 2013-2016

Prenatal Risk Factors and Perinatal and Postnatal Outcomes Associated With Maternal Opioid Exposure in an Urban, Low-Income, Multiethnic US Population

Export Citation

Share Paper